Global Legg-Calve-Perthes Disease Market, By Phases (Necrosis, Fragmentation, Reossification, Remodeling), Treatment (Non-Surgical Methods, Surgical Methods), Diagnosis (Physical Examination, X-ray, Magnetic Resonance Imaging (MRI), Ultrasound, Others), Dosage (Tablet, Injection, Others), Route of Administration (Oral, Intravenous, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Legg-Calve-Perthes Disease Market
Legg-Calve-Perthes disease market is expected to gain market growth in the forecast period of 2021-2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 4% in the above mentioned forecast period.
Perthes disease is another name for Legg-Calve-Perthes disease. It is a rare condition in which the blood flow to the ball-shaped head of the thighbone is momentarily blocked off. The thighbone's head compresses as a result, and the area becomes inflamed and irritating. The condition Legg-Calve-Perthes (LCPD) affects children between the ages of four and ten. Individuals with the illness develop osteoarthritis, a painful joint disorder that affects the hips, at a young age. Due to bone abnormalities, people with Legg-Calve-Perthes disease are frequently shorter than healthy people.
The rise in the prevalence of Legg-Calve-Perthes disease and rising healthcare expenditure are the major factors influencing the market growth rate. Furthermore, technological advancement, growing government funding and rising initiatives by public and private organisations to spread awareness about the disease and its preventive options are the factors that will expand the Legg-Calve-Perthes disease market.
Moreover, the rise in the research and development activities and emerging new markets will provide beneficial opportunities for the Legg-Calve-Perthes disease market in the forecast period of 2021-2028.
However, high cost of the treatment and complications associated with the disease are the factors that will hinder the market growth. Lack of awareness will further challenge the Legg-Calve-Perthes disease market in the forecast period mentioned above.
This Legg-Calve-Perthes disease market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Legg-Calve-Perthes disease market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Legg-Calve-Perthes Disease Market Scope and Market Size
The Legg-Calve-Perthes disease market is segmented on the basis of phases, treatment, diagnosis, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of phases, the Legg-Calve-Perthes disease market is segmented into necrosis, fragmentation, reossification and remodeling.
- On the basis of treatment, the Legg-Calve-Perthes disease market is segmented into non-surgical and surgical methods. The non-surgical method is further sub-segmented into anti-inflammatory medications, casting and bracing, crutches, and others. Casting and bracing is divided into Newington brace, Toronto orthosis, Scottish rite orthosis, broomstick plasters, and Birmingham orthosis. The others segment is divided into conventional calipers, Snyder slings, slings with crutches, and traction. The surgical method is further sub-segmented into femoral osteotomy, innominate osteotomy, a combination of femoral osteotomy, and innominate osteotomy.
- On the basis of diagnosis, the Legg-Calve-Perthes disease market is segmented into physical examination, x-ray, magnetic resonance imaging (MRI), ultrasound and others.
- On the basis of dosage, the Legg-Calve-Perthes disease market is segmented into tablet, injection and others.
- On the basis of route of administration, the Legg-Calve-Perthes disease market is segmented into oral, intravenous and others.
- On the basis of end-users, the Legg-Calve-Perthes disease market is segmented into clinic, hospital and others.
The Legg-Calve-Perthes disease market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Legg-Calve-Perthes Disease Market Country Level Analysis
Legg-Calve-Perthes disease market is analyzed and market size information is provided by the country, phases, treatment, diagnosis, dosage, route of administration, end-users and distribution channel as referenced above.
The countries covered in the Legg-Calve-Perthes disease market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the Legg-Calve-Perthes disease market due to the presence of major key players, high disposable income and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Legg-Calve-Perthes disease market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Legg-Calve-Perthes Disease Market Share Analysis
Legg-Calve-Perthes disease market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to Legg-Calve-Perthes disease market research.
Some of the major players operating in the Legg-Calve-Perthes disease market are Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Sun Pharmaceutical Industries Ltd., Amgen Inc., Johnson & Johnson Private Limited, Dr. Reddy’s Laboratories Ltd., BASF SE, Medical Devices Business Services, Inc., Stryker, Zimmer Biomet, F. Hoffmann-La Roche Ltd., Mylan N.V., Sanofi, Eli Lilly and Company, Bayer AG, AbbVie Inc., Aurobindo Pharma, Merck & Co., Inc., Bristol-Myers Squibb Company, AstraZeneca, 3M, and Biogen, among others.
SKU-